Ningbo MedicalSystem Biotechnology Co Ltd Tangible Net Worth Ratio
Ningbo MedicalSystem Biotechnology Co Ltd tangible net worth ratio. Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Tangible Net Worth Ratio of 95.5% as of September 2025. This metric is calculated by deducting intangible assets (CN¥131.46 Million) from net assets (CN¥2.95 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 300439 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
Tangible net worth ratio of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. This chart shows how Ningbo MedicalSystem Biotechnology Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 95.5%, reflecting net assets of CN¥2.95 Billion with intangible assets of CN¥131.46 Million CNY. See 300439 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Ningbo MedicalSystem Biotechnology Co Ltd Tangible Net Worth Ratio by Year (2011–2024)
Ningbo MedicalSystem Biotechnology Co Ltd tangible net worth ratio by year from 2011 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Ningbo MedicalSystem Biotechnology Co Lt (300439) total market value.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 95.4% | CN¥2.93 Billion | CN¥135.43 Million | CN¥3.71 Billion | ▲ +0.1 pp |
| 2023 | 95.3% | CN¥2.71 Billion | CN¥127.85 Million | CN¥3.49 Billion | ▲ +0.0 pp |
| 2022 | 95.2% | CN¥2.52 Billion | CN¥120.19 Million | CN¥3.58 Billion | ▲ +1.4 pp |
| 2021 | 93.8% | CN¥2.39 Billion | CN¥148.37 Million | CN¥3.59 Billion | ▲ +3.5 pp |
| 2020 | 90.3% | CN¥1.69 Billion | CN¥163.40 Million | CN¥3.25 Billion | ▲ +2.7 pp |
| 2019 | 87.6% | CN¥1.39 Billion | CN¥171.64 Million | CN¥3.74 Billion | ▼ -4.0 pp |
| 2018 | 91.6% | CN¥2.27 Billion | CN¥190.55 Million | CN¥4.60 Billion | ▲ +0.1 pp |
| 2017 | 91.5% | CN¥2.29 Billion | CN¥193.79 Million | CN¥4.28 Billion | ▲ +3.1 pp |
| 2016 | 88.5% | CN¥1.83 Billion | CN¥210.99 Million | CN¥3.42 Billion | ▼ -6.7 pp |
| 2015 | 95.2% | CN¥1.29 Billion | CN¥62.37 Million | CN¥1.45 Billion | ▲ +4.2 pp |
| 2014 | 91.0% | CN¥415.13 Million | CN¥37.38 Million | CN¥621.25 Million | ▼ -7.8 pp |
| 2013 | 98.8% | CN¥308.32 Million | CN¥3.64 Million | CN¥470.92 Million | ▲ +0.7 pp |
| 2012 | 98.1% | CN¥202.58 Million | CN¥3.84 Million | CN¥331.23 Million | ▲ +1.6 pp |
| 2011 | 96.5% | CN¥110.84 Million | CN¥3.86 Million | CN¥179.16 Million | — |